Drinks containing probiotic bacteria can help reduce diarrhea among older people, which may reduce length of stay in hospital and save the NHS money, say ImperialCollege researchers at HammersmithHospital in a study published today.
Between 5 percent and 25 percent of patients experience diarrhea, including Clostridium difficile associated diarrhea, as a complication of treatment with antibiotics.
Researchers set out to find whether probiotic drinks, which contain live micro-organisms, are helpful in reducing diarrhea related to antibiotic use.
They identified 135 people from three London hospitals who were all aged over 50 and receiving antibiotics for various reasons, such as for respiratory infection.
The patients were split at random into two groups. One was given a commercially available probiotic yoghurt drink while the other received a long-life, sterile milkshake. Neither group knew which drink they received.
Drinks were given twice a day, within 48 hours of the people starting antibiotic therapy and continued for one week after the antibiotics were stopped. The people were also contacted for follow up four weeks later.
Nursing staff monitored bowel movements and when there was evidence of diarrhea, samples were taken for analysis.
Of the 113 patients who were able to be contacted for follow-up, results showed the group taking probiotic drinks fared much better. Only 12 percent of those people developed antibiotic-associated diarrhea, compared to 34 percent of the other group.
Of the probiotic group of patients, none developed C.difficile associated diarrhoea, compared to 17 percent of people in the other group.
Apart from the health benefits, the researchers say that considerable savings may be made from greater use of probiotic drinks.
The researchers estimate cost of supplying the probiotic drink to prevent one case of C.difficile associated diarrhea to be £60. Previous published research suggests that treating one case of C.difficile can cost on average £4,000 because of increased length of stay and use of drugs.
Source: British Medical Journal
Â
Â
Â
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.